
Acne and Hirsutism in Women — Assess, Investigate & Treat
Acne and hirsutism are the two common skin signs of androgen action; they often occur together [1][4]
Hirsutism is excess terminal hair in a male pattern; it affects 5 to 15% of women [1]
Causes of hirsutism: PCOS 71%, idiopathic hyperandrogenism 15%, idiopathic hirsutism 10%, non-classic CAH 3%, tumours 0.3% [1]
The severity of hair growth does not reliably follow the testosterone level [1]
The combined pill is first-line for hirsutism in women not seeking pregnancy; add an antiandrogen after 6 months if needed [1][2]
Acne: topical retinoid at every severity; oral antibiotics for 12 weeks at most; isotretinoin for severe disease [3]
Both conditions reduce quality of life; ask about distress [1]

How to score: grade each of the nine areas 1 to 4 as pictured, or 0 if there is no terminal hair; add them for a total of 0 to 36
| Population | Abnormal score [1] |
|---|---|
| British and US Black and White women | 8 or more |
| Mediterranean, Hispanic, Middle Eastern | 9 or more |
| South American | 6 or more |
| Asian (as reported) | 2 or more |
Indian women: no cut-off was given in the sources read; 8 or more is commonly used (from memory)
Limits: the score is subjective, and shaving, waxing or laser lowers it; ask what she removes [1]
Hypertrichosis is different: fine, generalised hair that is not androgen-driven [1]
Drugs that cause hair growth: anabolic steroids, testosterone, valproate, ciclosporin, danazol, glucocorticoids, minoxidil [1]
| Test | When |
|---|---|
| Total testosterone [1][2] | Every woman with an abnormal hirsutism score |
| Early-morning total and free testosterone, specialty assay [2] | Normal first result but moderate or severe hair growth, irregular cycles, or progression |
| Early-morning 17-hydroxyprogesterone [2] | To screen for non-classic CAH; follicular phase, or any day if cycles are infrequent |
| DHEAS [1] | High-risk women or proven hyperandrogenism; adrenal source |
| Prolactin and thyroid tests [1] | Especially with suggestive symptoms |
| Pelvic ultrasound [1] | Ovarian morphology; suspected tumour |
| Cushing or acromegaly tests [1] | Only with clinical features |
Do not test androgens in a woman with regular cycles and only local unwanted hair with a normal score [2]
Acne alone with regular cycles and no hirsutism needs no hormone tests (from memory)
No numeric cut-offs for testosterone or 17-hydroxyprogesterone were given in the sources read; use your laboratory ranges
| Option | Detail |
|---|---|
| Lifestyle change [2] | Recommended for women with obesity, including PCOS |
| Combined oral contraceptive [1][2] | First-line if not seeking pregnancy; no pill is preferred; lowest effective oestrogen dose if obese or over 39 |
| Spironolactone 100 to 200 mg daily [1] | Add after 6 months of the pill, or start with reliable contraception; breast tenderness, high potassium, irregular bleeding |
| Finasteride 2.5 mg daily [1] | Alternative antiandrogen; high risk to a male fetus |
| Flutamide [1][2] | Avoid: liver toxicity |
| Metformin, pioglitazone [1][2] | Not effective for hirsutism alone |
| GnRH agonist [1][2] | Only for severe hyperandrogenism when other treatment fails |
| Eflornithine cream twice daily [1] | Facial hair; improvement in 6 to 8 weeks |
| Cyproterone-containing pills | Widely used in India; not covered in the sources read (from memory) |
Hair removal: laser or light for dark hair, with 40 to 80% reduction; electrolysis for white or blonde hair [1][2]
Darker skin: long-wavelength lasers (Nd:YAG or diode) with skin cooling [2]
Facial laser can paradoxically increase hair in Mediterranean and Middle Eastern women [2]
| Severity | Treatment [3] |
|---|---|
| Mild, comedonal | Topical retinoid alone (adapalene, tretinoin) once daily |
| Mild to moderate, inflammatory | Retinoid plus benzoyl peroxide; topical clindamycin only with benzoyl peroxide, 12 weeks at most |
| Moderate to severe | Add oral doxycycline 50 to 100 mg once or twice daily, with topicals; 12 weeks or less |
| Severe nodular, scarring, or resistant | Oral isotretinoin 0.5 mg/kg/day, rising to 1 mg/kg/day; total 120 to 150 mg/kg |
| Maintenance | Topical retinoid after oral treatment stops |
| Hormonal option | Evidence |
|---|---|
| Combined pill [3][4] | For acne with hirsutism, irregular cycles, or premenstrual flares; improvement takes 3 months or more; matches antibiotics by 6 months |
| Spironolactone 50 to 150 mg daily [4] | Off-label; 150 mg beat doxycycline at 6 months in one trial; potassium checks only with risk factors |
| Clascoterone 1% cream [4] | Topical antiandrogen; costly; availability in India not checked |
| Flutamide [3] | Not recommended |
Allow 8 weeks before judging any acne treatment [3]
Never use an antibiotic alone, topical or oral [3]
| Drug | Pregnancy and safety |
|---|---|
| Isotretinoin [3] | Contraindicated; reliable contraception and monthly pregnancy tests |
| Spironolactone, finasteride [1] | Avoid in pregnancy; risk of feminising a male fetus |
| Tetracyclines; topical tretinoin, tazarotene [3] | Avoid in pregnancy |
| Acceptable in pregnancy [3] | Benzoyl peroxide, azelaic acid, topical clindamycin or erythromycin |
| Combined pill: do not use [4] | Migraine with aura; age 35 or more and smoking 15 or more cigarettes a day |
| Combined pill: clot risk [4] | About 8 to 10 per 10,000 woman-years; higher with drospirenone than levonorgestrel |
Spironolactone: high potassium in 16.7% of women aged 46 to 65 against 0.9% of younger women; avoid with kidney disease [4]
Testing every hormone in a woman with mild acne and regular cycles
Missing virilisation because the examination stopped at the face [1]
Changing treatment at 2 or 3 months for hair [1][2]
Antiandrogen without contraception [2]
Metformin as the hair treatment [1][2]
Long or repeated antibiotic courses for acne [3]
Steroid-containing “fairness” creams as a cause of acne and facial hair (from memory)
Ignoring distress; ask, and treat hair removal as part of care [1]
HAIRS
| Abbreviation | Meaning |
|---|---|
| CAH | Congenital adrenal hyperplasia; “non-classic” is the mild, late-onset form |
| DHEAS | Dehydroepiandrosterone sulphate; an adrenal androgen |
| FG score | Ferriman-Gallwey score for hirsutism |
| GnRH | Gonadotrophin-releasing hormone |
| Nd:YAG | Neodymium-doped yttrium aluminium garnet; a long-wavelength laser |
| PCOS | Polycystic ovary syndrome |
| 17-OHP | 17-hydroxyprogesterone; the screening test for CAH |
| The pill | Combined oral contraceptive (oestrogen plus progestin) |
| doi | Digital object identifier of a paper |
[1] Matheson E, Bain J. Hirsutism in women. Am Fam Physician 2019;100(3):168-175.
[2] Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2018;103(4):1233. (Read as the Society’s recommendations page.)
[3] Ogé LK, Broussard A, Marshall MD. Acne vulgaris: diagnosis and treatment. Am Fam Physician 2019;100(8):475-484.
[4] Smith CA, Gosnell E, Karatas TB, et al. Hormonal therapies for acne: a comprehensive update for dermatologists. Dermatol Ther (Heidelb) 2025;15(1):45-59. doi:10.1007/s13555-024-01324-8.

No comments:
Post a Comment